X0306 4 2015-03-03 0 0001488613 Foundation Medicine, Inc. FMI 0001585005 Kafka Steven J. 150 SECOND STREET C/O FOUNDATION MEDICINE, INC. CAMBRIDGE MA 02141 0 1 0 0 Chief Operating Officer Common Stock 2015-03-03 4 M 0 20656 4.16 A 25336 D Common Stock 2015-03-03 4 S 0 20656 47.6834 D 4680 D Common Stock 2015-03-03 4 M 0 3124 4.16 A 7804 D Common Stock 2015-03-03 4 S 0 3124 47.693 D 4680 D Common Stock 2015-03-03 4 M 0 9344 7.12 A 14024 D Common Stock 2015-03-03 4 S 0 9344 47.5659 D 4680 D Stock Option (right to buy) 4.16 2015-03-03 4 M 0 20656 0.00 D 2023-03-07 Common Stock 20656 20674 D Stock Option (right to buy) 4.16 2015-03-03 4 M 0 3124 0.00 D 2023-03-07 Common Stock 3124 6248 D Stock Opiton (right to buy) 7.12 2015-03-03 4 M 0 9344 0.00 D 2023-05-22 Common Stock 9344 35156 D The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $47.50 to $47.92, inclusive. The reporting person undertakes to provide Foundation Medicine, Inc., any security holder of Foundation Medicine, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $47.60 to $47.75, inclusive. The reporting person undertakes to provide Foundation Medicine, Inc., any security holder of Foundation Medicine, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $47.51 to $47.61, inclusive. The reporting person undertakes to provide Foundation Medicine, Inc., any security holder of Foundation Medicine, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. This option is a non-qualified portion of an option granted on March 7, 2013 that vested 25% on January 2, 2014 and then vests in equal quarterly installments until fully vested on January 2, 2017. This option is a non-qualified portion of an option granted on March 7, 2013 that vests in equal quarterly installments beginning on June 7, 2013 until fully vested on March 7, 2017. This option was granted on May 22, 2013 and vests in equal quarterly installments beginning on August 22, 2013 until fully vested on May 22, 2017. Robert Hesslein, as Attorney-in-Fact for Steven J. Kafka 2015-03-05